Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorExpósito, José-
dc.contributor.authorLinares, Isabel-
dc.contributor.authorCastillo, Isabel-
dc.contributor.authorMartínez, Miguel-
dc.contributor.authorVargas, Pilar-
dc.contributor.authorHerruzo, Ismael-
dc.contributor.authorMedina, José Antonio-
dc.contributor.authorPalacios, Amalia-
dc.contributor.authorBayo, Eloísa-
dc.contributor.authorPeracaula, Francisco-
dc.contributor.authorJaén, Javier-
dc.contributor.authorSánchez, José Antonio-
dc.contributor.authorOrtiz, María José-
dc.identifier.citationExpósito J, Linares I, Castillo I, Martínez M, Vargas P, Herruzo I, et al. Evaluation of the utilization of external radiotherapy in the treatment of localized prostate cancer in Andalusia, Spain. Radiat Oncol. 2015; 10:265es
dc.identifier.issn1748-717X (Online)-
dc.descriptionJournal Article;es
dc.description.abstractBACKGROUND Around 27,000 new cases of prostate cancer are diagnosed every year in Spain and 5400 die from this disease. Radiotherapy (RT), alone or combined, has proven to be effective as initial treatment in patients with localized disease. Our objective was to evaluate the use of external beam RT (EBRT) in our region, comparing the indication rate and irradiation rate and examining variability in its application among hospitals. METHODS We conducted a review of RT guidelines and indication studies for prostate cancer (% expected irradiation). Data were gathered from all twelve public healthcare centers in Andalusia (Spain) on RT-treated prostate cancer patients during 2013 (% actual irradiation) and from nine of the centers on RT discharge reports. Information was classified according to type of hospital, tumor risk category and RT treatment (technique, dosage, volume, toxicity). RESULTS The estimated RT rate was 67 % (1289/1917), 43 % were aged > 70 years, 44.7 % had ECOG performance status of 0); 44.7 % had high-risk tumors; 57 % underwent RT associated with hormone therapy; 70 % of patients receiving RT were treated with 3D planning (30 % IGRT); and doses were 70-76 Gy in 70 % of cases and >76 Gy in 10.7 %. Acute gastrointestinal and genitourinary toxicities were < grade 2 in 79 and 89 % of patients, respectively. An irradiation rate significantly below the mean for the study was found in four provinces. There was a significant difference among provinces in the distribution of risk groups. CONCLUSIONS Underutilization of EBRT was estimated to be around 30 % in prostate cancer patients, with an elevated variability in irradiation rates among hospitals related to differences in available technology and in the distribution of patients with different risk levels. These data should be a matter of concern to regional health managers, given the negative and measurable impact on the survival of
dc.publisherBioMed Centrales
dc.relation.ispartofRadiation Oncology (London, England)es
dc.subjectProstate canceres
dc.subjectAlta del pacientees
dc.subjectNeoplasias de la próstataes
dc.subjectSistema urogenitales
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.subject.meshMedical Subject Headings::Check Tags::Malees
dc.subject.meshMedical Subject Headings::Health Care::Health Care Facilities, Manpower, and Services::Health Services::Patient Care::Hospitalization::Patient Dischargees
dc.subject.meshMedical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasmses
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Riskes
dc.subject.meshMedical Subject Headings::Geographicals::Geographic Locations::Europe::Spaines
dc.subject.meshMedical Subject Headings::Anatomy::Urogenital Systemes
dc.titleEvaluation of the utilization of external radiotherapy in the treatment of localized prostate cancer in Andalusia,
dc.rights.accessRightsAcceso abiertoes
dc.contributor.authoraffiliation[Expósito,J; Linares,I; Vargas,P; Castillo,I] Radiotherapy and Oncology Department, Granada General Hospital, Granada, Spain. [Martínez,M] Radiotherapy and Oncology Department, Jaén General Hospital, Jaén, Spain. [Herruzo,I] Radiotherapy and Oncology Department, Carlos Haya University Hospital, Málaga, Spain. [Medina,JA] Radiotherapy and Oncology Department, Virgen de la Victoria University Hospital, Málaga, Spain. [Palacios,A] Radiotherapy and Oncology Department, Reína Sofía University Hospital, Córdoba, Spain. [Bayo,E] Radiotherapy and Oncology Department, Juan Ramón Jiménez Hospital, Huelva, Spain. [Peracaula,F] Radiotherapy and Oncology Department, Punta de Europa Algeciras Hospital, Algeciras, Cádiz, Spain.. [Jaén,J] Radiotherapy and Oncology Department, Puerta del Mar University Hospital, Cádiz, Spain. [Sánchez,JA] Radiotherapy and Oncology Department, Virgen Macarena University Hospital, Sevilla, Spain. [Ortiz,MJ] Radiotherapy and Oncology Department, Virgen del Rocío University Hospital, Sevilla,
Appears in Collections:01- Artículos - Complejo Hospitalario Universitario de Granada
01- Artículos - Hospital Virgen del Rocío
01- Artículos - Hospital Virgen Macarena
01- Artículos - Hospital Puerta del Mar
01- Artículos - AGS Campo de Gibraltar
01- Artículos - Hospital Juan Ramón Jiménez
01- Artículos - Hospital Reina Sofía
01- Artículos - Hospital Virgen de la Victoria
01- Artículos - Hospital Regional de Málaga
01- Artículos - Complejo Hospitalario de Jaén

Files in This Item:
File Description SizeFormat 
ExpositoJ_EvaluationOfTheUtilization.pdfArtículo publicado548,01 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons